JPMorgan Starts Denali Therapeutics Inc. (DNLI) at Overweight

January 2, 2018 6:57 AM EST Send to a Friend
JPMorgan initiates coverage on Denali Therapeutics Inc. (NASDAQ: DNLI) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login